82.6
mL/min
83
mL/min
1
0
0
0
82.6
mL/min
83
mL/min
1
0
0
0
The Creatinine Clearance Calculator uses the Cockcroft-Gault equation, one of the earliest and most widely used formulas for estimating kidney function. Published in 1976 by Donald Cockcroft and Henry Gault, this equation estimates creatinine clearance (CrCl) from serum creatinine, age, weight, and sex. Despite the development of newer equations like CKD-EPI, the Cockcroft-Gault formula remains clinically relevant because many drug dosing guidelines and pharmacokinetic studies were developed using this specific equation.
The Cockcroft-Gault formula is: CrCl (mL/min) = [(140 - age) x weight (kg)] / [72 x serum creatinine (mg/dL)] x 0.85 if female. This equation captures three key physiological relationships: creatinine production decreases with age (the 140 minus age term), creatinine production is proportional to muscle mass approximated by body weight, and females have lower creatinine production per kilogram due to lower average muscle mass (the 0.85 correction factor). The denominator normalizes for the relationship between creatinine production and serum concentration.
An important distinction between creatinine clearance and glomerular filtration rate is that CrCl overestimates true GFR by approximately 10-15% because creatinine undergoes tubular secretion in addition to glomerular filtration. This overestimation is consistent and predictable in healthy individuals but can be altered by drugs that inhibit tubular secretion (trimethoprim, cimetidine) or in advanced kidney disease where secretion contributes a larger fraction of total clearance.
The primary contemporary use of the Cockcroft-Gault equation is drug dosing adjustment. The United States Food and Drug Administration historically required pharmacokinetic studies to report renal function using this equation, and many package inserts still reference Cockcroft-Gault CrCl for dose modification thresholds. For example, dosing for direct oral anticoagulants, metformin, and many antibiotics specify CrCl cutoffs derived from Cockcroft-Gault. While CKD-EPI eGFR often yields similar clinical dosing decisions, discrepancies can occur, particularly in elderly, obese, or underweight patients.
A significant limitation of the Cockcroft-Gault equation is its use of actual body weight, which overestimates CrCl in obese patients because excess adipose tissue does not proportionally increase creatinine production. Various adjustments have been proposed, including using ideal body weight for patients significantly above IBW, or using adjusted body weight (IBW plus 40% of the difference between actual and ideal weight) for obese patients. The choice of weight parameter can substantially affect the calculated CrCl and subsequent drug dosing decisions.
The equation was developed and validated using 24-hour urine creatinine clearance measurements from 249 men with stable kidney function at a Veterans Affairs hospital. The original validation population was exclusively male, with the 0.85 female adjustment factor derived from population-level estimates of lower creatinine production in women. The equation has not been refit for contemporary standardized creatinine assays (IDMS-traceable), which may introduce systematic bias compared to older assays. Despite these limitations, its long track record and integration into drug dosing literature ensure its continued clinical relevance.
The Cockcroft-Gault equation estimates creatinine clearance as: CrCl = [(140 - age) x weight] / (72 x serum creatinine), multiplied by 0.85 for females. Age accounts for declining creatinine production with aging, weight approximates muscle mass and creatinine generation, and the sex factor corrects for lower muscle mass in females. The result is in mL/min (not normalized to body surface area).
Normal CrCl is approximately 90-140 mL/min in healthy young adults. Values are reported in absolute mL/min (not indexed to BSA like eGFR). For drug dosing, compare the CrCl to the specific thresholds in the drug prescribing information. In obese patients, consider using adjusted body weight. CrCl overestimates true GFR by 10-15% due to tubular secretion of creatinine.
Inputs
Results
CrCl of 82.6 mL/min indicates mildly reduced kidney function. Most medications do not require dose adjustment at this level.
Inputs
Results
CrCl of 26.0 mL/min indicates severe kidney impairment. Many drugs require significant dose reduction or avoidance at this level.
The Cockcroft-Gault equation estimates creatinine clearance from serum creatinine, age, weight, and sex: CrCl = [(140 - age) x weight] / (72 x Scr) x 0.85 if female. Published in 1976, it remains widely used for drug dosing adjustments because many pharmacokinetic studies reference this equation.
Use actual body weight for normal-weight patients. For obese patients (more than 20% above ideal body weight), consider using adjusted body weight: IBW + 0.4 x (actual weight - IBW). Using actual weight in obese patients overestimates CrCl because adipose tissue does not increase creatinine production proportionally.
CrCl estimates total creatinine clearance (filtration plus tubular secretion), overestimating true GFR by 10-15%. eGFR estimates glomerular filtration rate specifically. CrCl is reported in absolute mL/min while eGFR is indexed to 1.73 m2 BSA. Many drug dosing guidelines use CrCl (Cockcroft-Gault) rather than eGFR.
Pharmacokinetic studies for many drugs used Cockcroft-Gault CrCl to define renal function categories. FDA drug labels reference the equation used in the original studies. Switching to a different equation could change which dose adjustment category a patient falls into, potentially affecting safety.
Accuracy decreases in elderly patients due to reduced muscle mass (lower creatinine production not fully captured by the age term) and often low body weight. CrCl may be overestimated in cachectic elderly patients. Clinical judgment and, when possible, measured 24-hour CrCl may be more reliable in this population.
No. The Cockcroft-Gault equation was developed and validated in adults only. Pediatric GFR estimation uses the Schwartz equation, which incorporates height and age-specific creatinine coefficients appropriate for developing kidneys and growing bodies.
Some clinicians round up low creatinine values (e.g., 0.6 or 0.7) to 1.0 mg/dL in elderly or cachectic patients to avoid overestimating CrCl. This practice is controversial but aims to provide a conservative estimate for drug dosing in patients whose low creatinine reflects low muscle mass rather than excellent kidney function.
Very low weight may underestimate CrCl in muscular patients, while high weight overestimates CrCl in obese patients. The equation was developed in a population with relatively normal body composition. For clinical drug dosing at weight extremes, pharmacist consultation is recommended.
It was published in 1976 by Donald Cockcroft and Henry Gault in the journal Nephron. The equation was derived from 249 male patients at a VA hospital and validated against 24-hour urine creatinine clearance measurements. It predated IDMS-standardized creatinine assays now used in most laboratories.
Use CKD-EPI 2021 for diagnosing and staging chronic kidney disease (KDIGO recommendation). Use Cockcroft-Gault for drug dosing when the drug label specifically references CrCl. In many cases, both equations yield similar clinical decisions, but discrepancies are most likely in elderly, obese, or very thin patients.
Roboculator Team
The Roboculator Team explains calculations, planning tools, and practical formulas in clear language for real-life situations.
How helpful was this calculator?
Be the first to rate!
eGFR Calculator (CKD-EPI 2021)
Nephrology Calculators
MDRD GFR Calculator
Nephrology Calculators
Schwartz Formula (Pediatric GFR)
Nephrology Calculators
Kidney Failure Risk Equation (KFRE)
Nephrology Calculators
BUN/Creatinine Ratio Calculator
Nephrology Calculators
Fractional Excretion of Sodium (FENa)
Nephrology Calculators
